Kore Private Wealth’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Bought
Maintained
Sold
Kore Private Wealth's AST Position: Q1 2019 in Review
Kore Private Wealth sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 208 shares.
Kore Private Wealth first reported a position in AST in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.
- Kore Private Wealth reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
- Kore Private Wealth sold 208 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
- Kore Private Wealth first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2018 and held it in 1 quarter.
- Kore Private Wealth's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q4 2018.
- 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.
Based on Kore Private Wealth's 13F filing for Q1 2019, filed 16 May 2019.